Genmab

+$0.11 (+0.25%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Genmab and other stocks, options, and ETFs commission-free!

About GMAB

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases.

CEO
Jan G. J. van de Winkel
Employees
781
Headquarters
Copenhagen, Capital Region
Founded
1999

GMAB Key Statistics

Market Cap
28.61B
Price-Earnings Ratio
33.39
Dividend Yield
—
Average Volume
429.82K
High Today
$43.81
Low Today
$43.02
Open Price
$43.23
Volume
614.54K
52 Week High
$44.83
52 Week Low
$29.28

GMAB Earnings

$0.00
$2.53
$5.05
$7.58
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Available Aug 11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure